Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Pramipexole Dihydrochloride Sustained Release Tablets

Approval Number

国药准字HJ20140583

CompanyBoehringer Ingelheim International GmbH

Registration Date

May 22, 2024

Previous Approval Numbers

H20140583

Drug Information

Generic Name

盐酸普拉克索缓释片

Trade Name

森福罗

Dosage Form

片剂

Strength

0.375mg

Drug Type

化学药品

Registration Date

May 22, 2024

Expiry Date

May 21, 2029

Company Information

Applicant Company

Company NameBoehringer Ingelheim International GmbH

Company Address

Binger Strasse 173, 55216 Ingelheim am Rhein, Germany

Manufacturing Company

Company NameRottendorf Pharma GmbH

Company Address

Ostenfelder Straße 51-61, 59320 Ennigerloh，Germany

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

盐酸普拉克索缓释片 - NMPA 批准文号 | MedPath